MoonLake Immunotherapeutics (MLTX) Income from Non-Controlling Interests (2022 - 2025)
MoonLake Immunotherapeutics (MLTX) posted Income from Non-Controlling Interests of -$591,000 for Q4 2025, compared with -$790,000 a year earlier.
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Income from Non-Controlling Interests (2022 - 2025) Analysis & Trends
For FY2025, MoonLake Immunotherapeutics' Income from Non-Controlling Interests came in at -$3 million.
- In prior years, MoonLake Immunotherapeutics' Income from Non-Controlling Interests was -$2.31 million in FY2024, -$8.07 million in FY2023 and -$14.53 million in FY2022.
- The Q4 2025 figure stands as the highest quarterly Income from Non-Controlling Interests since Q2 2024.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior quarters was -$965,000 (Q3 2025), -$831,000 (Q2 2025) and -$615,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | MoonLake Immunotherapeutics | 971.07 Mn | -698.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -591,000.00 |
| Sep 30, 2025 | -965,000.00 |
| Jun 30, 2025 | -831,000.00 |
| Mar 31, 2025 | -615,000.00 |
| Dec 31, 2024 | -790,000.00 |
| Sep 30, 2024 | -724,000.00 |
| Jun 30, 2024 | -492,000.00 |
| Mar 31, 2024 | -302,000.00 |
| Dec 31, 2023 | -450,457.00 |
| Sep 30, 2023 | -2.19 Mn |
| Jun 30, 2023 | -2.21 Mn |
| Mar 31, 2023 | -3.21 Mn |
| Dec 31, 2022 | 639,890.00 |
| Sep 30, 2022 | -4.63 Mn |
| Jun 30, 2022 | -5.30 Mn |
API Access
MoonLake Immunotherapeutics Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MLTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "MLTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MLTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();